Translating Nanotechnology to Vascular Disease

[1]  S. Nattel,et al.  Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. , 1997, The New England journal of medicine.

[2]  M. Miyazaki,et al.  Oxidative stress is involved in the development of experimental abdominal aortic aneurysm: a study of the transcription profile with complementary DNA microarray. , 2002, Journal of vascular surgery.

[3]  A. Robert,et al.  Elastin-elastase-atherosclerosis revisited. , 1998, Atherosclerosis.

[4]  Gary D Bader,et al.  Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry , 2002, Nature.

[5]  J. Mesirov,et al.  Chemosensitivity prediction by transcriptional profiling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Ware,et al.  Therapeutic angiogenesis in cardiovascular disease , 2003, Nature Reviews Drug Discovery.

[7]  G Marrazza,et al.  Detection of human apolipoprotein E genotypes by DNA electrochemical biosensor coupled with PCR. , 2000, Clinical chemistry.

[8]  D. Hochstrasser,et al.  Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. , 1996, Biotechnology & genetic engineering reviews.

[9]  C. Lieber,et al.  Nanowire Nanosensors for Highly Sensitive and Selective Detection of Biological and Chemical Species , 2001, Science.

[10]  B. Strauss,et al.  The extracellular matrix in balloon arterial injury: a novel target for restenosis prevention. , 1998, Progress in cardiovascular diseases.

[11]  J. Boyle,et al.  Vascular smooth muscle cell detachment from elastin and migration through elastic laminae is promoted by chondroitin sulfate-induced "shedding" of the 67-kDa cell surface elastin binding protein. , 1992, Experimental cell research.

[12]  P. Brown,et al.  Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M B Eisen,et al.  Delineating developmental and metabolic pathways in vivo by expression profiling using the RIKEN set of 18,816 full-length enriched mouse cDNA arrays , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E J Topol,et al.  Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. , 1998, Circulation.

[15]  C. Grines,et al.  Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris , 2002, Circulation.

[16]  J F Cornhill,et al.  Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodeling. , 1995, Circulation research.

[17]  S. P. Fodor,et al.  Light-generated oligonucleotide arrays for rapid DNA sequence analysis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Hendel,et al.  Phase 1/2 Placebo-Controlled, Double-Blind, Dose-Escalating Trial of Myocardial Vascular Endothelial Growth Factor 2 Gene Transfer by Catheter Delivery in Patients With Chronic Myocardial Ischemia , 2002, Circulation.

[19]  C Di Mario,et al.  Long-term clinical follow-up after successful repeat percutaneous intervention for stent restenosis. , 1997, Journal of the American College of Cardiology.

[20]  Lucy J. Holt,et al.  The use of recombinant antibodies in proteomics. , 2000, Current opinion in biotechnology.

[21]  D. Belin,et al.  The plasminogen activator/plasmin system. , 1991, The Journal of clinical investigation.

[22]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[23]  J. Loscalzo,et al.  PPACK attenuates plasmin-induced changes in endothelial integrity. , 1993, Thrombosis research.

[24]  A. Jacobs.  Coronary stents--have they fulfilled their promise? , 1999, The New England journal of medicine.

[25]  R. Ross,et al.  Cell biology of atherosclerosis. , 1995, Annual review of physiology.

[26]  R. Mecham,et al.  Impaired elastin fiber assembly related to reduced 67-kD elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate. , 1991, The Journal of clinical investigation.

[27]  M. Ezekowitz,et al.  Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction. , 1998, The American journal of cardiology.

[28]  S. Marx,et al.  Bench to bedside: the development of rapamycin and its application to stent restenosis. , 2001, Circulation.

[29]  D. Schrijvers,et al.  Gene Expression Profiling of Apoptosis-Related Genes in Human Atherosclerosis: Upregulation of Death-Associated Protein Kinase , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[30]  Robert Langer,et al.  Moving smaller in drug discovery and delivery , 2002, Nature Reviews Drug Discovery.

[31]  M. Dake,et al.  In vivo vascular engineering: directed migration of smooth muscle cells to limit neointima. , 2002, Tissue engineering.

[32]  A. Clowes,et al.  Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. , 1996, Circulation research.

[33]  M. Leon,et al.  Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization. , 1996, Journal of the American College of Cardiology.

[34]  N. Yamamoto,et al.  Microarray fabrication with covalent attachment of DNA using Bubble Jet technology , 2000, Nature Biotechnology.

[35]  R. Mecham,et al.  Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes , 1984, The Journal of cell biology.

[36]  Benno J. Rensing,et al.  Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents: One-Year Angiographic and Intravascular Ultrasound Follow-Up , 2001, Circulation.

[37]  T. A. Desai,et al.  Micro- and nanoscale structures for tissue engineering constructs. , 2000, Medical engineering & physics.

[38]  K. Hahn,et al.  Shedding Light on Cell Signaling: Interpretation of FRET Biosensors , 2003, Science's STKE.

[39]  M. Leon,et al.  Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. , 1996, Circulation.

[40]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[41]  Michael Keusgen,et al.  Biosensors: new approaches in drug discovery , 2002, Naturwissenschaften.

[42]  C. Bauters,et al.  Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. , 1998, Circulation.

[43]  G. Koehl,et al.  Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor , 2002, Nature Medicine.

[44]  B. Thiede,et al.  Protein identification from 2-DE gels by MALDI mass spectrometry. , 1997, Mass spectrometry reviews.

[45]  É. Allaire,et al.  Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response. , 1997, The Annals of thoracic surgery.

[46]  M. Dake,et al.  Enhancement of neointima formation with tissue-type plasminogen activator. , 2001, Journal of vascular surgery.

[47]  M. Rabinovitch,et al.  Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular matrix‐bound basic fibroblast growth factor , 1996, Journal of cellular physiology.

[48]  Julie H. Campbell,et al.  Inhibition of Neointimal Formation by Natural Heparan Sulfate Proteoglycans of the Arterial Wall a , 1997, Annals of the New York Academy of Sciences.

[49]  Yudong D. He,et al.  Functional Discovery via a Compendium of Expression Profiles , 2000, Cell.

[50]  S. P. Fodor,et al.  Multiplexed biochemical assays with biological chips , 1993, Nature.

[51]  D. Berman,et al.  The VIVA Trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis , 2003, Circulation.

[52]  P. Jones,et al.  Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. , 2000, The Journal of clinical investigation.

[53]  P. Brown,et al.  Drug target validation and identification of secondary drug target effects using DNA microarrays , 1998, Nature Medicine.

[54]  F. Neumann,et al.  Gene Expression Profiling of Human Stent-Induced Neointima by cDNA Array Analysis of Microscopic Specimens Retrieved by Helix Cutter Atherectomy: Detection of FK506-Binding Protein 12 Upregulation , 2001, Circulation.

[55]  P. Benos,et al.  Genomic analysis of immediate/early response to shear stress in human coronary artery endothelial cells. , 2002, Physiological genomics.

[56]  J. Ware,et al.  Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. , 2002, The Journal of thoracic and cardiovascular surgery.

[57]  M. Rabinovitch,et al.  Functional interplay between interleukin-1 receptor and elastin binding protein regulates fibronectin production in coronary artery smooth muscle cells. , 1996, Experimental cell research.

[58]  L. Liotta,et al.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. , 1981, Cancer research.

[59]  D. J. Nagel,et al.  Nanotechnology-Enabled Sensors: Possibilities, Realities, and Applications , 2003 .

[60]  T. Helgason,et al.  Differentiated vascular myocytes: are they involved in neointimal formation? , 1996, The Journal of clinical investigation.

[61]  Timothy B. Stockwell,et al.  The Sequence of the Human Genome , 2001, Science.

[62]  M. Dake,et al.  Development of a platform to evaluate and limit in-stent restenosis. , 2002, Tissue engineering.

[63]  R. Lederman,et al.  Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial , 2002, The Lancet.

[64]  H. Clark,et al.  Optical nanosensors for chemical analysis inside single living cells. 2. Sensors for pH and calcium and the intracellular application of PEBBLE sensors. , 1999, Analytical chemistry.

[65]  Catherine Zandonella,et al.  Cell nanotechnology: The tiny toolkit , 2003, Nature.

[66]  P. Armstrong,et al.  Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. , 1994, Circulation research.

[67]  Matthew A. Cooper,et al.  Optical biosensors in drug discovery , 2002, Nature Reviews Drug Discovery.

[68]  G. Wilson,et al.  Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation. , 1996, The Journal of clinical investigation.

[69]  Tetsuya Haruyama,et al.  Micro- and nanobiotechnology for biosensing cellular responses. , 2003, Advanced drug delivery reviews.

[70]  Ruedi Aebersold,et al.  The study of macromolecular complexes by quantitative proteomics , 2003, Nature Genetics.

[71]  B. Cravatt,et al.  Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype , 2002, Nature Biotechnology.

[72]  R J Carroll,et al.  Genomic profiles and predictive biological networks in oxidant-induced atherogenesis. , 2003, Physiological genomics.

[73]  S. Fields,et al.  A novel genetic system to detect protein–protein interactions , 1989, Nature.

[74]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[75]  J. Hacia.  Resequencing and mutational analysis using oligonucleotide microarrays , 1999, Nature Genetics.

[76]  M. Bednarski,et al.  Tumor Regression by Targeted Gene Delivery to the Neovasculature , 2002, Science.

[77]  M. Dake,et al.  In vivo vascular engineering of vein grafts: directed migration of smooth muscle cells by perivascular release of elastase limits neointimal proliferation. , 2002, Journal of vascular and interventional radiology : JVIR.

[78]  J. Hartikainen,et al.  Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia: Phase II Results of the Kuopio Angiogenesis Trial (KAT) , 2003, Circulation.

[79]  A Curtis,et al.  Topographical control of cells. , 1997, Biomaterials.

[80]  H. Ishibashi-Ueda,et al.  Coronary atherosclerosis and interventions: Pathological sequences and restenosis , 1999, Pathology international.

[81]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[82]  H. Nakamura,et al.  Substratum‐Bound Elastin Pept ide In hi bits Aortic Smooth Muscle Cell Migration in Vitro , 1987, Arteriosclerosis.

[83]  J. Pearlman,et al.  Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. , 1999, Circulation.

[84]  P. Libby,et al.  The molecular bases of restenosis. , 1997, Progress in cardiovascular diseases.

[85]  T. Vo‐Dinh,et al.  Biosensors and biochips: advances in biological and medical diagnostics , 2000, Fresenius' journal of analytical chemistry.

[86]  J. Wojcik,et al.  The protein–protein interaction map of Helicobacter pylori , 2001, Nature.

[87]  Ward Casscells,et al.  Migration of Smooth Muscle and Endothelial Cells: Critical Events in Restenosis , 1992, Circulation.

[88]  A. Eisen,et al.  Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[89]  T. Henry,et al.  Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial , 2002, Circulation.

[90]  M. Ferrari,et al.  Prospects for microtechnology and nanotechnology in bioengineering of replacement microvessels. , 2002, Archives of pathology & laboratory medicine.

[91]  M. Rabinovitch,et al.  Post-cardiac transplant arteriopathy in piglets is associated with fragmentation of elastin and increased activity of a serine elastase. , 1994, The American journal of pathology.

[92]  Dean Y. Li,et al.  Elastin is an essential determinant of arterial morphogenesis , 1998, Nature.

[93]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[94]  M. Daly,et al.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.

[95]  J. Yates,et al.  Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. , 1995, Analytical chemistry.

[96]  Frank Dudbridge,et al.  Haplotype tagging for the identification of common disease genes , 2001, Nature Genetics.

[97]  S. P. Fodor,et al.  Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two–colour fluorescence analysis , 1996, Nature Genetics.